Back to Nature: Prescription Dietary Supplements Cash in on Cholesterol R&D Setbacks

Executive Summary

The Players Who Will Shape Health Care Reform in 2009

Executive Summary

Branded for Failure? Industry Hesitant to Adopt FDA Brand Name Review Pilot

Executive Summary

Reinforcements at Last: CDER Hiring Process Well Underway

Medicare Market Shares: Why the Big Plans Don’t Mind Losing Ground

Novartis Bets Big on Meningitis: Wall Street Awaits Blockbuster Vaccine Franchise

The First 100 Days: FDA’s Frank Torti Outlines His Vision for the Agency

Health Policy Players You Should Get To Know

On Guard: FDA Launches Sentinel